(Q28240192)

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

A mouse cerberus/Dan-related gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Cbfa1 isoforms exert functional differences in osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Carboxylated calcium-binding proteins and vitamin K.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Increased bone formation in osteocalcin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Identification of a DNA sequence involved in osteoblast-specific gene expression via interaction with helix-loop-helix (HLH)-type transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Active conservation of noncoding sequences revealed by three-way species comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

VISTA : visualizing global DNA sequence alignments of arbitrary length

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

An osteogenesis-related transcription factor, core-binding factor A1, is constitutively expressed in the chondrocytic cell line TC6, and its expression is upregulated by bone morphogenetic protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Differentiation of human marrow stromal precursor cells: bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Bone morphogenetic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Heterogeneity of latent transforming growth factor-beta isolated from bone matrix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200

Mutations in the gene encoding the latency-associated peptide of TGF-β1 cause Camurati-Engelmann disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306249200